Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.39 Insider Own1.50% Shs Outstand36.72M Perf Week-9.78%
Market Cap677.48M Forward P/E- EPS next Y-1.59 Insider Trans-1.45% Shs Float34.73M Perf Month4.24%
Income-45.00M PEG- EPS next Q-0.09 Inst Own- Short Float26.25% Perf Quarter1.37%
Sales593.20M P/S1.14 EPS this Y-107.80% Inst Trans8.94% Short Ratio10.89 Perf Half Y-14.58%
Book/sh26.96 P/B0.68 EPS next Y-15.20% ROA-1.80% Target Price23.22 Perf Year-23.32%
Cash/sh10.87 P/C1.70 EPS next 5Y- ROE-4.80% 52W Range16.00 - 36.83 Perf YTD-46.98%
Dividend- P/FCF3.59 EPS past 5Y54.30% ROI3.50% 52W High-50.37% Beta0.97
Dividend %- Quick Ratio1.40 Sales past 5Y54.10% Gross Margin77.00% 52W Low14.22% ATR0.80
Employees545 Current Ratio1.50 Sales Q/Q24.30% Oper. Margin1.30% RSI (14)45.05 Volatility3.70% 4.33%
OptionableYes Debt/Eq0.81 EPS Q/Q- Profit Margin-7.60% Rel Volume0.61 Prev Close18.45
ShortableYes LT Debt/Eq0.81 EarningsAug 03 BMO Payout- Avg Volume836.85K Price18.27
Recom2.70 SMA20-0.89% SMA50-1.57% SMA200-17.36% Volume381,945 Change-0.95%
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Nov-19-15Reiterated Deutsche Bank Hold $50 → $43
Sep-03-15Resumed Deutsche Bank Hold $75 → $71
Sep-01-15Initiated Raymond James Outperform $75
Aug-18-15Resumed Jefferies Buy $80
Jun-12-15Initiated Deutsche Bank Hold $75
Jun-09-15Initiated Guggenheim Buy
May-18-15Reiterated Leerink Partners Outperform $60 → $85
Jan-26-15Resumed FBR Capital Mkt Perform $42
Sep-30-14Upgrade FBR Capital Mkt Perform → Outperform $21 → $36
Aug-14-14Initiated FBR Capital Mkt Perform $21
Jan-22-14Downgrade Ladenburg Thalmann Buy → Neutral
Oct-18-13Upgrade Robert W. Baird Neutral → Outperform $25 → $26
Sep-22-17 08:14AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : September 22, 2017 Capital Cube
Sep-07-17 12:22PM  ETFs with exposure to AMAG Pharmaceuticals, Inc. : September 7, 2017 Capital Cube
08:00AM  AMAG Pharmaceuticals Appoints Laura Williams, M.D. as Senior Vice President of Clinical Development GlobeNewswire
Sep-05-17 12:34PM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
02:59AM  AMAG Pharmaceuticals (AMAG) Down 6.6% Since Earnings Report: Can It Rebound? Zacks
Sep-01-17 05:13PM  AMAG's Filing for Feraheme's Label Expansion Accepted by FDA Zacks +5.39%
Aug-31-17 08:00AM  AMAG Announces U.S. FDA Filing Acceptance and Six-Month Review of Feraheme® (ferumoxytol) for the Treatment of All Adult Patients With Iron Deficiency Anemia GlobeNewswire
Aug-29-17 06:00PM  Edited Transcript of AMAG earnings conference call or presentation 3-Aug-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-10-17 09:41AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : August 10, 2017 Capital Cube
Aug-08-17 08:00AM  AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality GlobeNewswire
Aug-04-17 08:41AM  AMAG Pharma (AMAG) Incurs Narrower-than-Expected Loss in Q2 Zacks +6.63%
01:27AM  AMAG Pharmaceuticals reports 2Q loss Associated Press
Aug-03-17 07:02AM  AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
07:00AM  AMAG Completes Feraheme® (ferumoxytol) FDA Submission for the Treatment of All Adult Patients With Iron Deficiency Anemia GlobeNewswire
05:40AM  Investor Network: AMAG Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-24-17 08:20AM  Spark Therapeutics (ONCE) Worth a Look: Stock Gains 5.7% Zacks
08:00AM  AMAG Pharmaceuticals Launches Intrarosa (prasterone) in the U.S. a Novel Product to Treat Moderate to Severe Dyspareunia Due to Menopause GlobeNewswire
Jul-20-17 08:00AM  AMAG Pharmaceuticals to Host Second Quarter 2017 Financial Results Conference Call and Webcast on Thursday, August 3, 2017 at 8:00 a.m. ET GlobeNewswire
Jul-05-17 01:17PM  AMAG Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMAG) : July 5, 2017 Capital Cube
09:53AM  AMAG Pharmaceuticals Focuses on Product Development & Buyouts Zacks
Jul-04-17 08:56AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : July 4, 2017 Capital Cube
Jun-26-17 04:17PM  Could An FDA Delay Snag This Biotech's Pre-Term Birth Drug? Investor's Business Daily
08:00AM  AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Makena® (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector GlobeNewswire
Jun-02-17 06:12AM  Why Is AMAG Pharmaceuticals (AMAG) Down 15.6% Since the Last Earnings Report? Zacks
Jun-01-17 08:00AM  AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio GlobeNewswire
May-31-17 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
May-16-17 08:00AM  AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs GlobeNewswire
May-15-17 09:30AM  Alpha & Omega Semiconductor, AMAG Pharmaceuticals and Trade Desk highlighted as Zacks Bull and Bear of the Day Zacks
08:00AM  AMAG Pharmaceuticals Completes Financing Transactions in Support of Future Growth Strategy GlobeNewswire
07:01AM  Bear of the Day: AMAG Pharmaceuticals (AMAG) Zacks
May-12-17 02:06PM  AMAG Pharmaceuticals, Inc. -- Moody's upgrades AMAG's sr. notes to Ba3; affirms B2 CFR Moody's
May-10-17 08:55AM  What Makes AMAG Pharmaceuticals (AMAG) a Strong Sell? Zacks
08:00AM  AMAG Pharmaceuticals to Host Analyst Day on May 24th in New York GlobeNewswire
May-05-17 03:47PM  ETFs with exposure to AMAG Pharmaceuticals, Inc. : May 5, 2017 Capital Cube
07:00AM  AMAG Pharmaceuticals Announces Pricing of $300 Million of 3.25% Convertible Senior Notes Due 2022 GlobeNewswire
May-04-17 04:01PM  AMAG Pharmaceuticals, Inc. -- Moody's: AMAG's proposed refinancing credit positive Moody's
03:30PM  Edited Transcript of AMAG earnings conference call or presentation 2-May-17 12:00pm GMT Thomson Reuters StreetEvents
10:35AM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube
May-03-17 04:17PM  AMAG Pharmaceuticals Announces Proposed Offering of $250 Million of Convertible Senior Notes due 2022 GlobeNewswire
11:11AM  AMAG Pharma (AMAG) Incurs Loss in Q1, Revenues Rise Y/Y Zacks
May-02-17 09:19AM  Biotech Movers: Luminex, Exelixis, AMAG Pharmaceuticals TheStreet.com -12.98%
07:55AM  AMAG Pharmaceuticals reports 1Q loss Associated Press
07:01AM  AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
07:00AM  Investor Network: AMAG Pharmaceuticals, Inc. to Host Earnings Call Accesswire
07:00AM  AMAG Announces Positive Topline Data From Phase 3 Feraheme® (ferumoxytol) Label Expansion Study GlobeNewswire
Apr-26-17 08:00AM  AMAG Pharmaceuticals to Present at the Deutsche Bank Health Care Conference GlobeNewswire
Apr-25-17 09:00AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : April 25, 2017 Capital Cube
08:00AM  AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance GlobeNewswire
Apr-19-17 08:00AM  AMAG Pharmaceuticals to Host First Quarter 2017 Financial Results Conference Call and Webcast on Tuesday, May 2, 2017 at 8:00 a.m. ET GlobeNewswire
Apr-18-17 10:33AM  AMAG Files for FDA Approval of Subcutaneous Form of Makena Zacks
Apr-17-17 08:00AM  AMAG Submits Supplemental New Drug Application to FDA for Makena® (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use GlobeNewswire
Apr-12-17 01:20PM  AMAG Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMAG) : April 12, 2017 Capital Cube
Apr-11-17 08:16AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMAG-US : April 11, 2017 Capital Cube
Apr-07-17 08:33AM  15 companies with outsized sales growth and widening profit margins MarketWatch
Apr-05-17 04:43PM  15 companies with outsized sales growth and widening profit margins
Apr-04-17 08:54AM  AMAG Pharmaceuticals stock surges 4% after closing $50 mln licensing agreement for menopause drug MarketWatch
08:00AM  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosa (Prasterone) GlobeNewswire
Mar-31-17 09:30AM  Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals Zacks
Mar-30-17 10:12AM  5 Toxic Stocks to Get Rid Of or Play Short to Make Gains
10:12AM  5 Toxic Stocks to Get Rid Of or Play Short to Make Gains Investopedia
Mar-28-17 08:00AM  AMAG Pharmaceuticals to Present at the Needham Healthcare Conference GlobeNewswire
Mar-22-17 09:23AM  Billionaires' Worst Healthcare Stock Picks for 2017 (So Far) Motley Fool
Mar-21-17 08:16AM  AMAG Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMAG-US : March 21, 2017 Capital Cube -5.52%
Mar-20-17 07:30AM  Palatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women PR Newswire
Mar-14-17 01:50PM  Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG) Insider Monkey
Mar-06-17 08:29AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Fi
08:00AM  AMAG Announces Management Changes and New Commercial Appointments GlobeNewswire
Mar-01-17 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Feb-27-17 08:00AM  AMAG and Palatin Announce Rekynda Data Presentations at the International Society for the Study of Womens Sexual Health Annual Meeting GlobeNewswire
Feb-24-17 01:04PM  AMAG PHARMACEUTICALS INC. Financials
Feb-21-17 04:41PM  AMAG Pharmaceuticals, Inc. -- Moody's revises outlook on AMAG to stable, affirms B2 CFR at Moody's
06:02AM  AMAG PHARMACEUTICALS INC. Files SEC form 10-K, Annual Report
Feb-16-17 12:54PM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: 2016 By the Numbers : February 16, 2017
11:44AM  AMAG Pharmaceuticals Inks $60M Drug Deal at Investopedia
Feb-15-17 11:01AM  AMAG Pharmaceuticals, Inc. :AMAG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
10:08AM  AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates
Feb-14-17 11:05PM  Edited Transcript of AMAG earnings conference call or presentation 14-Feb-17 1:00pm GMT
09:30AM  Biotech Premarket Movers: Pacific Biosciences of California, AMAG, Global Blood Therapeutics
08:00AM  AMAG Pharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today
07:34AM  AMAG Pharmaceuticals reports 4Q loss
07:14AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and F
07:07AM  Q4 2016 AMAG Pharmaceuticals Inc Earnings Release - Before Market Open
07:01AM  AMAG Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
07:00AM  AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa (Prasterone) GlobeNewswire
Feb-10-17 09:29AM  Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
09:28AM  Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb-09-17 08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conference GlobeNewswire
Feb-07-17 08:00AM  AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2016 Financial Results Conference Call and Webcast on Tuesday, February 14, 2017 at 8:00 a.m. ET GlobeNewswire
Feb-03-17 08:09AM  AMAG PHARMACEUTICALS INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD Discl
08:06AM  AMAG Down Despite Positive Data on Makena Auto-Injector
08:00AM  AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda (bremelanotide) GlobeNewswire
07:00AM  Palatin Technologies Announces Closing of License Agreement with AMAG Pharmaceuticals for North American Rights to Rekynda PR Newswire
Feb-02-17 03:12PM  Here's Why AMAG Pharmaceuticals Is Falling Today at Motley Fool -7.46%
10:40AM  Why Amag Pharmaceuticals Is Sinking Despite Positive Top-Line Results
08:00AM  AMAG Pharmaceuticals Announces Positive Topline Results from Definitive Pharmacokinetic Study for Makena Subcutaneous Administration GlobeNewswire
Jan-19-17 09:35AM  Is AMAG Pharmaceuticals (AMAG) A Good Value Pick?
Jan-11-17 10:22AM  AMAG Pharmaceuticals, Inc. Value Analysis (NASDAQ:AMAG) : January 11, 2017
07:54AM  AMAG Pharma downgraded by Needham
Jan-10-17 04:30PM  Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda PR Newswire
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, manufactures, develops, and commercializes therapeutics for women's health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families. In addition, it has a option agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. It has a license agreement with Palatin Technologies, Inc. to research, develop, and commercialize Rekynda, an investigational product designed to be an on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, as well as with Endoceutics, Inc. to develop and commercialize pharmaceutical products with dehydroepiandrosterone; and development and license agreement with Antares Pharma, Inc. to develop, use, sell, and offer for sale and import and export the Makena auto-injector. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vittiglio JosephSVP, General CounselAug 29Sale16.751,25020,93833,504Aug 30 04:03 PM
Krop JulieSVP Clinical & Regulatory, CMOJul 13Sale20.004,93898,76028,336Jul 14 04:26 PM
Krop JulieSVP Clinical & Regulatory, CMOMay 01Sale24.451,89146,23536,777May 02 05:07 PM
Krop JulieSVP Clinical & Regulatory, CMOOct 20Sale24.804,938122,46223,668Oct 20 04:07 PM